These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 25946093)
1. Effects of 39 Compounds on Calmodulin-Regulated Adenylyl Cyclases AC1 and Bacillus anthracis Edema Factor. Lübker C; Seifert R PLoS One; 2015; 10(5):e0124017. PubMed ID: 25946093 [TBL] [Abstract][Full Text] [Related]
2. Inhibitors of Bacillus anthracis edema factor. Seifert R; Dove S Pharmacol Ther; 2013 Nov; 140(2):200-12. PubMed ID: 23850654 [TBL] [Abstract][Full Text] [Related]
3. Different Roles of N-Terminal and C-Terminal Domains in Calmodulin for Activation of Bacillus anthracis Edema Factor. Lübker C; Dove S; Tang WJ; Urbauer RJ; Moskovitz J; Urbauer JL; Seifert R Toxins (Basel); 2015 Jul; 7(7):2598-614. PubMed ID: 26184312 [TBL] [Abstract][Full Text] [Related]
4. Identification of FDA-Approved Small Molecules Capable of Disrupting the Calmodulin-Adenylyl Cyclase 8 Interaction through Direct Binding to Calmodulin. Hayes MP; Soto-Velasquez M; Fowler CA; Watts VJ; Roman DL ACS Chem Neurosci; 2018 Feb; 9(2):346-357. PubMed ID: 28968502 [TBL] [Abstract][Full Text] [Related]
5. Membranous adenylyl cyclase 1 activation is regulated by oxidation of N- and C-terminal methionine residues in calmodulin. Lübker C; Urbauer RJ; Moskovitz J; Dove S; Weisemann J; Fedorova M; Urbauer JL; Seifert R Biochem Pharmacol; 2015 Jan; 93(2):196-209. PubMed ID: 25462816 [TBL] [Abstract][Full Text] [Related]
6. Identification of a selective small-molecule inhibitor of type 1 adenylyl cyclase activity with analgesic properties. Brust TF; Alongkronrusmee D; Soto-Velasquez M; Baldwin TA; Ye Z; Dai M; Dessauer CW; van Rijn RM; Watts VJ Sci Signal; 2017 Feb; 10(467):. PubMed ID: 28223412 [TBL] [Abstract][Full Text] [Related]
9. MD simulations of anthrax edema factor: calmodulin complexes with mutations in the edema factor "switch a" region and docking of 3'-deoxy ATP into the adenylyl cyclase active site of wild-type and mutant edema factor variants. Zhao J; Roy SA; Nelson DJ J Biomol Struct Dyn; 2003 Oct; 21(2):159-70. PubMed ID: 12956602 [TBL] [Abstract][Full Text] [Related]
10. Structural and kinetic analyses of the interaction of anthrax adenylyl cyclase toxin with reaction products cAMP and pyrophosphate. Guo Q; Shen Y; Zhukovskaya NL; Florián J; Tang WJ J Biol Chem; 2004 Jul; 279(28):29427-35. PubMed ID: 15131111 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the adenylyl cyclase toxin, edema factor, from Bacillus anthracis by a series of 18 mono- and bis-(M)ANT-substituted nucleoside 5'-triphosphates. Taha H; Dove S; Geduhn J; König B; Shen Y; Tang WJ; Seifert R Naunyn Schmiedebergs Arch Pharmacol; 2012 Jan; 385(1):57-68. PubMed ID: 21947230 [TBL] [Abstract][Full Text] [Related]
12. Optimization of a 1,3,4-oxadiazole series for inhibition of Ca Kaur J; Soto-Velasquez M; Ding Z; Ghanbarpour A; Lill MA; van Rijn RM; Watts VJ; Flaherty DP Eur J Med Chem; 2019 Jan; 162():568-585. PubMed ID: 30472604 [TBL] [Abstract][Full Text] [Related]
13. Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds. Brand CS; Hocker HJ; Gorfe AA; Cavasotto CN; Dessauer CW J Pharmacol Exp Ther; 2013 Nov; 347(2):265-75. PubMed ID: 24006339 [TBL] [Abstract][Full Text] [Related]
14. Antagonism of calmodulin-stimulated adenylate cyclase by trifluoperazine, calmidazolium and W-7 in rat cerebellar membranes. Ahlijanian MK; Cooper DM J Pharmacol Exp Ther; 1987 May; 241(2):407-14. PubMed ID: 3106618 [TBL] [Abstract][Full Text] [Related]
15. Distinct mechanisms of regulation by Ca2+/calmodulin of type 1 and 8 adenylyl cyclases support their different physiological roles. Masada N; Ciruela A; Macdougall DA; Cooper DM J Biol Chem; 2009 Feb; 284(7):4451-63. PubMed ID: 19029295 [TBL] [Abstract][Full Text] [Related]
16. Calcium dependence of the interaction between calmodulin and anthrax edema factor. Ulmer TS; Soelaiman S; Li S; Klee CB; Tang WJ; Bax A J Biol Chem; 2003 Aug; 278(31):29261-6. PubMed ID: 12724328 [TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection. Shen Y; Zhukovskaya NL; Zimmer MI; Soelaiman S; Bergson P; Wang CR; Gibbs CS; Tang WJ Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3242-7. PubMed ID: 14978283 [TBL] [Abstract][Full Text] [Related]
18. Distinct interactions of 2'- and 3'-O-(N-methyl)anthraniloyl-isomers of ATP and GTP with the adenylyl cyclase toxin of Bacillus anthracis, edema factor. Suryanarayana S; Wang JL; Richter M; Shen Y; Tang WJ; Lushington GH; Seifert R Biochem Pharmacol; 2009 Aug; 78(3):224-30. PubMed ID: 19492438 [TBL] [Abstract][Full Text] [Related]
19. Halogen-Dance-Based Synthesis of Phosphonomethoxyethyl (PME) Substituted 2-Aminothiazoles as Potent Inhibitors of Bacterial Adenylate Cyclases. Česnek M; Šafránek M; Dračínský M; Tloušťová E; Mertlíková-Kaiserová H; Hayes MP; Watts VJ; Janeba Z ChemMedChem; 2022 Jan; 17(1):e202100568. PubMed ID: 34636150 [TBL] [Abstract][Full Text] [Related]